California biomonitoring data: Comparison to NHANES and interpretation in a risk assessment context

Angerer, 2011, Human biomonitoring assessment values: approaches and data requirements, Int. J. Hyg. Environ. Health, 214, 348, 10.1016/j.ijheh.2011.06.002 Aylward, 2008, Biomonitoring equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7), Regul. Toxicol. Pharmacol., 51, S37, 10.1016/j.yrtph.2008.05.006 Aylward, 2009, Derivation of biomonitoring equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP), Regul. Toxicol. Pharmacol., 55, 259, 10.1016/j.yrtph.2009.09.003 Aylward, 2010, Biomonitoring equivalents for hexachlorobenzene, Regul. Toxicol. Pharmacol., 58, 25, 10.1016/j.yrtph.2010.06.003 Aylward, 2012, Interpreting variability in population biomonitoring data: role of elimination kinetics, J. Exp. Sci. Environ. Epidemiol., 22, 398, 10.1038/jes.2012.35 Aylward, 2013, Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals, Environ. Health Perspect, 121, 287, 10.1289/ehp.1205740 Centers for Disease Control and Prevention (CDC). 2014. National Report on Human Exposure to Environmental Chemicals – Explore the Fourth Report and Updated Tables. Available: http://www.cdc.gov/exposurereport/data_tables/index.html#DataTablesByChemicalGroup (accessed 12.12.14.). Dourson, 2013, Advancing human health risk assessment: integrating recent advisory committee recommendations, Crit. Rev. Toxicol., 43, 467, 10.3109/10408444.2013.807223 Hays, 2007, Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective, Regul. Toxicol. Pharmacol., 47, 96, 10.1016/j.yrtph.2006.08.004 Hays, 2008, Biomonitoring equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9), Regul. Toxicol. Pharmacol., 51, S49, 10.1016/j.yrtph.2008.05.008 Krishnan, 2011, Biomonitoring equivalents for 2,2′,4,4',5-pentabromodiphenylether (PBDE-99), Regul. Toxicol. Pharmacol., 60, 165, 10.1016/j.yrtph.2011.03.011 Krishnan, 2010, Biomonitoring equivalents for bisphenol A (BPA), Regul. Toxicol. Pharmacol., 58, 18, 10.1016/j.yrtph.2010.06.005 Krishnan, 2010, Biomonitoring equivalents for triclosan, Regul. Toxicol. Pharmacol., 58, 10, 10.1016/j.yrtph.2010.06.004 Li, 2010, Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling, J. Expo. Sci. Environ. Epidemiol, 20, 526, 10.1038/jes.2009.41 National Academy of Sciences (NAS), 2000 National Research Council (NRC), 2006 Patterson, 2009, Levels in the U.S. population of those persistent organic pollutants (2003-2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements, Environ. Sci. Technol., 43, 1211, 10.1021/es801966w Preau, 2010, Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study, Environ. Health Perspect., 118, 1748, 10.1289/ehp.1002231 St-Amand, 2014, Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context, Toxicol. Lett., 231, 126, 10.1016/j.toxlet.2014.10.019 Tyrrell, 2013, Associations between socioeconomic status and environmental toxicant concentrations in adults in the USA: NHANES 2001-2010, Environ. Int., 59, 328, 10.1016/j.envint.2013.06.017 United States Environmental Protection Agency (US EPA), 2013 Whitehead, 2015, Concentrations of persistent organic pollutants in California women's serum and residential dust, Environ. Res, 136, 57, 10.1016/j.envres.2014.10.009 Ye, 2011, Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections, Environ. Health Perspect., 119, 983, 10.1289/ehp.1002701 Zota, 2014, Temporal trends in phthalate exposures: findings from the National Health and Nutrition Examination Survey, 2001-2010, Environ. Health Perspect., 122, 235, 10.1289/ehp.1306681